Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06021613 · ClinicalTrials.gov registry record · NA
The MARY-JANE Cannabis and Heart Rhythm Trial
A NA study of Premature Atrial Contractions and Premature Ventricular Contractions, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT06021613 is a NA study of Premature Atrial Contractions and Premature Ventricular Contractions that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 100 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT06021613, a NA study of Premature Atrial Contractions and Premature Ventricular Contractions, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Despite recreational cannabis now being legal in 23 states, where more than 100 million Americans reside, studies on the actual health effects are limited. This study is a randomized trial, where each participant will be instructed to consume or avoid cannabis on randomly assigned days during a 14-day monitoring period. The goal of this study is to answer the question: "Does cannabis use increase the frequency of 'early' and abnormal heart beats?" During the 14-day period, participants will wear an external heart monitor, a glucose monitor, and a fitness tracker to track heart rhythm, glucose levels, step counts, and sleep health. Participants will use a mobile app or a text messaging service for daily instructions/reminders on cannabis use, and short surveys. The investigators ask that participants smoke or vape cannabis at least once on days they are instructed to consume cannabis. Compelling evidence of heart and other health effects would be important to the clinical care of our patients.
Conditions Studied
Interventions
- BEHAVIORAL Randomized instructions
Study Locations (2)
California
- UCSF Medical Center at Parnassus - San Francisco
- UCSF Medical Center at Mission Bay - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06021613
The ClinicalTrials.gov registry entry for NCT06021613 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Premature Atrial Contractions appearing as the primary indexed condition, and to 1 intervention - of which Randomized instructions is the first listed.
NCT06021613 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06021613 about?
NCT06021613 is a clinical study titled "The MARY-JANE Cannabis and Heart Rhythm Trial". Despite recreational cannabis now being legal in 23 states, where more than 100 million Americans reside, studies on the actual health effects are limited. This study is a randomized trial, where each participant will be instructed to consume or avoid cannabis on randomly assigned days during a 14-d...
What is the current status of trial NCT06021613?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-01-18. Estimated completion is 2026-11.
What conditions does trial NCT06021613 study?
This clinical trial studies the following conditions: Premature Atrial Contractions, Premature Ventricular Contractions.
What interventions are being tested in trial NCT06021613?
The interventions under investigation include: Randomized instructions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06021613?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06021613 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Premature Atrial Contractions
All registered trials for this condition
Premature Ventricular Contractions
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.